309 related articles for article (PubMed ID: 10780795)
1. Double-blind study of cetirizine and loratadine versus placebo in patients with allergic rhinitis.
Nunes C; Ladeira S
J Investig Allergol Clin Immunol; 2000; 10(1):20-3. PubMed ID: 10780795
[TBL] [Abstract][Full Text] [Related]
2. Desloratadine and levocetirizine improve nasal symptoms, airflow, and allergic inflammation in patients with perennial allergic rhinitis: a pilot study.
Ciprandi G; Cirillo I; Vizzaccaro A; Civardi E; Barberi S; Allen M; Marseglia GL
Int Immunopharmacol; 2005 Dec; 5(13-14):1800-8. PubMed ID: 16275616
[TBL] [Abstract][Full Text] [Related]
3. Cetirizine, loratadine, or placebo in subjects with seasonal allergic rhinitis: effects after controlled ragweed pollen challenge in an environmental exposure unit.
Day JH; Briscoe M; Widlitz MD
J Allergy Clin Immunol; 1998 May; 101(5):638-45. PubMed ID: 9600501
[TBL] [Abstract][Full Text] [Related]
4. Loratadine versus cetirizine: assessment of somnolence and motivation during the workday.
Salmun LM; Gates D; Scharf M; Greiding L; Ramon F; Heithoff K
Clin Ther; 2000 May; 22(5):573-82. PubMed ID: 10868555
[TBL] [Abstract][Full Text] [Related]
5. Mizolastine provides effective symptom relief in patients suffering from perennial allergic rhinitis: a double-blind, placebo-controlled study versus loratadine.
Frèche C; Leynadier F; Horak F; Hide D; Gracia FD; Goos M; Bachert C; Horvath A; Antosova E; Verrecchia M; Soussen PB
Ann Allergy Asthma Immunol; 2002 Sep; 89(3):304-10. PubMed ID: 12269652
[TBL] [Abstract][Full Text] [Related]
6. Double-blind comparison of cetirizine and loratadine in children ages 2 to 6 years with perennial allergic rhinitis.
Sienra-Monge JJ; Gazca-Aguilar A; Del Rio-Navarro B
Am J Ther; 1999 May; 6(3):149-55. PubMed ID: 10423657
[TBL] [Abstract][Full Text] [Related]
7. Comparative onset of action and symptom relief with cetirizine, loratadine, or placebo in an environmental exposure unit in subjects with seasonal allergic rhinitis: confirmation of a test system.
Day JH; Briscoe M; Rafeiro E; Chapman D; Kramer B
Ann Allergy Asthma Immunol; 2001 Dec; 87(6):474-81. PubMed ID: 11770694
[TBL] [Abstract][Full Text] [Related]
8. Onset of action and efficacy of terfenadine, astemizole, cetirizine, and loratadine for the relief of symptoms of allergic rhinitis.
Day JH; Briscoe MP; Clark RH; Ellis AK; Gervais P
Ann Allergy Asthma Immunol; 1997 Aug; 79(2):163-72. PubMed ID: 9291422
[TBL] [Abstract][Full Text] [Related]
9. Comparison of efficacy and safety of cetirizine and ebastine in patients with perennial allergic rhinitis.
Murris-Espin M; Melac M; Charpentier JC; Didier A
Ann Allergy Asthma Immunol; 1998 May; 80(5):399-403. PubMed ID: 9609610
[TBL] [Abstract][Full Text] [Related]
10. Levocetirizine improves nasal obstruction and modulates cytokine pattern in patients with seasonal allergic rhinitis: a pilot study.
Ciprandi G; Cirillo I; Vizzaccaro A; Tosca MA
Clin Exp Allergy; 2004 Jun; 34(6):958-64. PubMed ID: 15196286
[TBL] [Abstract][Full Text] [Related]
11. A direct comparison of the efficacy of antihistamines in SAR and PAR: randomised, placebo-controlled studies with levocetirizine and loratadine using an environmental exposure unit - the Vienna Challenge Chamber (VCC).
Stübner P; Zieglmayer R; Horak F
Curr Med Res Opin; 2004 Jun; 20(6):891-902. PubMed ID: 15200748
[TBL] [Abstract][Full Text] [Related]
12. Comparative effects of desloratadine, fexofenadine, and levocetirizine on nasal adenosine monophosphate challenge in patients with perennial allergic rhinitis.
Lee DK; Gardiner M; Haggart K; Fujihara S; Lipworth BJ
Clin Exp Allergy; 2004 Apr; 34(4):650-3. PubMed ID: 15080821
[TBL] [Abstract][Full Text] [Related]
13. [In seasonal and perennial rhinitis. Superiority to standard H1 blockers].
MMW Fortschr Med; 2003 May; 145(22):51. PubMed ID: 12866281
[No Abstract] [Full Text] [Related]
14. A descriptive analysis of the use and cost of new-generation antihistamines in the treatment of allergic rhinitis: a retrospective database analysis.
Lee J; Cummins G; Okamoto L
Am J Manag Care; 2001 May; 7(4 Suppl):S103-12. PubMed ID: 11392821
[TBL] [Abstract][Full Text] [Related]
15. [Antihistaminics. Side effects also after raising dosage at the placebo level].
MMW Fortschr Med; 2003 May; 145(22):50-1. PubMed ID: 12866280
[No Abstract] [Full Text] [Related]
16. A 12-week placebo-controlled study of rupatadine 10 mg once daily compared with cetirizine 10 mg once daily, in the treatment of persistent allergic rhinitis.
Fantin S; Maspero J; Bisbal C; Agache I; Donado E; Borja J; Mola O; Izquierdo I;
Allergy; 2008 Jul; 63(7):924-31. PubMed ID: 18588560
[TBL] [Abstract][Full Text] [Related]
17. The effectiveness of levocetirizine in comparison with loratadine in treatment of allergic rhinitis--a meta-analysis.
Mösges R; König V; Köberlein J
Allergol Int; 2011 Dec; 60(4):541-6. PubMed ID: 21918368
[TBL] [Abstract][Full Text] [Related]
18. Comparison of mizolastine with loratadine in the treatment of perennial allergic rhinitis.
Bellioni P; Catalano B; Cervellera G; Filiaci F; Mira E; Carraro A
Rhinology; 1996 Jun; 34(2):101-4. PubMed ID: 8876072
[TBL] [Abstract][Full Text] [Related]
19. Loratadine treatment of rhinitis due to pollen allergy reduces epithelial ICAM-1 expression.
Ciprandi G; Pronzato C; Ricca V; Passalacqua G; Danzig M; Canonica GW
Clin Exp Allergy; 1997 Oct; 27(10):1175-83. PubMed ID: 9383258
[TBL] [Abstract][Full Text] [Related]
20. Comparison between nasal provocation tests and skin tests in patients treated with loratadine and cetirizine.
Persi L; Demoly P; Harris AG; Tisserand B; Michel FB; Bousquet J
J Allergy Clin Immunol; 1999 Apr; 103(4):591-4. PubMed ID: 10200006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
